Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis.
Indian J Ophthalmol
;
2011 July; 59(4): 318-319
Article
Dans Anglais
| IMSEAR
| ID: sea-136200
ABSTRACT
The purpose of the study was to report a case of choroidal neovascularization (CNV) secondary to ocular toxoplasmosis in an 18-year-old female patient. She was treated with a single intravitreal injection of ranibizumab. The CNV resolved as confirmed by fluorescein angiography and optical coherence tomography (OCT). The visual acuity improved to 20/30, which was maintained till the last follow-up visit at two years, without requisition of a repeat injection.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Rétinopathies
/
Femelle
/
Humains
/
Angiographie fluorescéinique
/
Maladies de la choroïde
/
Toxoplasmose oculaire
/
Adolescent
/
Cicatrice
/
Néovascularisation choroïdienne
/
Inhibiteurs de l'angiogenèse
langue:
Anglais
Texte intégral:
Indian J Ophthalmol
Année:
2011
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS